Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1312
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00136487 | Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer | ||
| NCT01782443 | Ziv-Aflibercept for Advanced Progressive Carcinoid Tumors | ||
| NCT00529035 | Ultra-Low Dose Interleukin-2 for Refractory Chronic Graft Versus Host Disease | ||
| NCT03675893 | RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer | ||
| NCT02028988 | Enzalutamide + External Beam Rt For Prostate | ||
| NCT00438854 | Dasatinib in Relapsed Chronic Lymphocytic Leukemia | ||
| NCT03392246 | A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer | ||
| NCT00215046 | Vinblastine and Methotrexate in Children With Pulmonary Vein Stenosis | ||
| NCT02268851 | A Phase I/Ib Safety and Efficacy Study of the PI3K-delta Inhibitor TGR-1202 and Ibrutinib in Patients With CLL or MCL | ||
| NCT01674842 | Cisplatin + RT for Triple Negative Breast Cancer | ||
| NCT00136422 | Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia | ||
| NCT02466061 | TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors | ||
| NCT00400946 | 05-001: Treatment of Acute Lymphoblastic Leukemia in Children | ||
| NCT05700461 | Drug Screening Using Novel IMD in Renal Cell Carcinoma | ||
| NCT03783546 | Acupuncture for Hot Flashes in Hormone Receptor-Positive Breast Cancer, a Randomized Controlled Trial | ||
| NCT01112527 | PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma | ||
| NCT03422003 | Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma | ||
| NCT04474626 | Isoquercetin in Sickle Cell Anemia | ||
| NCT00496379 | ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases | ||
| NCT03595917 | ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML | ||
| NCT00146588 | Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer | ||
| NCT04045470 | A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma | ||
| NCT02873962 | A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib | ||
| NCT00275262 | A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation | ||
| NCT00601146 | Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease | ||
| NCT01659203 | Proton or Photon RT for Retroperitoneal Sarcomas | ||
| NCT07551635 | SMARCA4/2 Inhibitor for POU2F3-Positive SCLC | ||
| NCT01283048 | Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma | ||
| NCT04141449 | A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation | ||
| NCT03147287 | Palbociclib After CDK and Endocrine Therapy (PACE) | ||
| NCT02158091 | A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL | ||
| NCT03236428 | Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma | ||
| NCT02670525 | Matched Targeted Therapy For High-Risk Leukemias and Myelodysplastic Syndrome | ||
| NCT01181271 | Tandem Auto-Allo Transplant for Lymphoma | ||
| NCT00418093 | Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma | ||
| NCT00280930 | Letrozole in Postmenopausal Women at Increased Risk for Breast Cancer | ||
| NCT00251407 | Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies | ||
| NCT00409292 | RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer | ||
| NCT03316599 | Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic Cancer | ||
| NCT00889187 | Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer | ||
| NCT04572763 | Copanlisib Plus Venetoclax in R/R DLBCL | ||
| NCT00095875 | Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial) | ||
| NCT01221766 | Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease | ||
| NCT02971956 | Pembrolizumab in Refractory Advanced Esophageal Cancer | ||
| NCT05765500 | RecoverPC: Relugolix vs GnRH Agonist in Quality of Life | ||
| NCT01978899 | Healthy Living After Cancer: Weight Management Pilot Study | ||
| NCT06488378 | Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer | ||
| NCT02470910 | Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning | ||
| NCT00148668 | Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer | ||
| NCT00398710 | A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia |
